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ABSTRACT 
 
 Direct oxidation of C-H bonds using non-heme iron catalysis has proven to be a highly useful 
transformation since its development in recent years.  The ability to directly install oxygen into a 
hydrocarbon framework negates the need for pre-oxidized materials, and allows for quick and efficient 
access to more diverse and complex molecules;  in some cases, access to motifs that would not 
otherwise be accessible is possible. Furthermore, ligation at the iron center with a tetra-dentate amine 
complex containing two adjacent, equatorial active sites on the metal has allowed for synthetically 
useful levels of reactivity, with the added benefit of predictable selectivity and even directing group 
effects.  In addition, the PDP ligand framework has been shown amenable to various steric and 
electronic modifications, allowing for tuning of reactivity and selectivity.  Key limitations are still 
prevalent in the methodology, however, including lack of an enantioselective variant, and little/no 
tolerance of certain common functional groups including amines and most aromatic rings.  This work 
describes development of novel substrate protection methods to address the functional group tolerance 
of nitrogen-containing substrates, with further application to oxidation of amino-acids and small 
peptides.   
  Due to inherent catalyst reactivity and reaction conditions, highly complex molecules with a 
variety of functional groups remain challenging for C-H oxidation, a process that is highly desired in 
academic and industrial settings alike.  The inherent ligation capabilities of nitrogen to iron (exemplified 
by the tetra-amine PDP ligand) obviate the difficulty in tolerating a substrate containing any variety of 
amine motifs.  Novel protection strategies using various electron-withdrawing group on nitrogen were 
developed which prevent this ligation, and allow for productive oxidation at distal sites on the molecule.  
Due to the abundance of various classes of amines, different protective group strategies were 
developed, depending on which type of amine was present. 
 Application of these protective schemes was then applied to amino-acid and peptide settings.  
An added benefit of an ester moiety adjacent to the amine allowed for simple nitrosulfonyl protection, 
whereby oxidation of aliphatic side chain residues was possible.  In other cases, certain residues were 
found to be oxidatively stable.  In dipeptide settings, selectivity trends were studied between various 
residues, and it was also found that residue position (N- vs. C- terminus) greatly affected reactivity 
trends.  Overall this process has been shown to greatly surpass current state of the art methods for 
amino-acid and peptide oxidation/diversification, and increases the synthetic potential for development 
of pharmaceuticals of this variety.
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CHAPTER 1 
IMPROVING FUNCTIONAL GROUP TOLERANCE OF NON-HEME IRON C-H OXIDATION VIA NOVEL 
SUBSTRATE PROTECTIVE GROUP STRATEGIES 
1.1 INTRODUCTION 
The C-H bond is increasingly being viewed as a new functional group, with the potential to be 
transformed selectively to C-O, C-N, and even C-C bonds.1  Of particular interest in our group is the 
formation of C-O bonds, which are prevalent in many natural products and pharmaceutical compounds.2  
The non-heme, small molecule Fe-catalyst developed in our group is a novel tool for oxidation of  
unactivated C-H bonds, owing to its mild conditions and predictable selectivities.3  As previously 
reported, Fe(PDP) 1 selects for:  1) 3o C-H bonds in preference to 2o and 1o C-H bonds; 2) C-H bonds 
distal to electron-withdrawing functionality (electron-rich C-H bonds); and 3) sterically accessible C-H 
bonds.  In addition, carboxylic acids were established to act as directing groups capable of overriding 
electronic preferences of the catalyst (Figure 1).   
 
Late-stage C-H oxidation allows for efficient syntheses of complex small molecules by limiting 
the need for functional group manipulations (oxidations/reductions; protecting group 
introduction/removal).  This direct installation of oxygen can be a powerful tool for construction of 
complex, highly functionalized motifs, both for synthetic streamlining as well as product diversification.  
A classic example of the ability of nature to build up densely functionalized motifs from relatively simple 
hydrocarbons is the biosynthesis of Taxol4 (Figure 2, A).  After production of Taxadiene via a cyclase 
enzyme, >20 different heme-based Cytochrome P450 tailoring enzymes introduce oxygen functionality 
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around the periphery of the hydrocarbon core with incredible levels of site-, chemo-, and 
stereoselectivity en route to fully oxygenated Taxolx.  Other natural enzymes like Methane Mono 
Oxygenase (MMO) and α-Ketoglutarate Dependent Oxygenase (αKGDO) achieve similar reactivity 
utilizing non-heme supported iron centers within the enzyme (Figure 2, B and C).  In these cases, a 
common motif is the “2-His-1-carboxylate triad”, where 2 Histidine residues and one carboxylate residue 
(Aspartic or Glutamic acid) support the iron center within the active site and throughout the oxidation 
process.  Although αKGDO and MMO differ in the number of iron atoms present in the active site 
(mononuclear and dinuclear, respectively), each can support a high-spin iron(IV) oxo species capable of 
selective and difficult oxidations (Figure 2, D and E).  In fact, MMO is one of the most intriguing of the 
natural non-heme oxo-enzymes due to its fascinating ability to transform a highly inert methane C-H 
bond (bond dissociation energy = 104 kcal/mol) into methanol, while over oxidation to formaldehyde is 
completely suppressed.       
 
 Achieving biomimetic levels of reactivity and selectivity using non-enzymatic, small-molecule 
systems is an active area of research in many laboratories.  While progress has been made with our non-
heme iron catalyst, much remains to be explored in the area of substrate scope, with emphasis on 
functional group tolerance (FGT).  To address this issue, we have explored rational catalyst design and 
novel protection strategies (substrate modification) to expand on current catalyst reactivity and 
selectivity capabilities.  With these advancements, great progress has been made in the areas of alkaloid 
oxidation (nitrogen tolerance) with application to amino acid and peptide oxidation. 
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1.2 RESULTS AND DISCUSSION  
 The primary goal of this work was to improve the functional group tolerance of the catalyst, 
specifically towards amine functionality.  Because alkaloids are a prominent class of biologically active 
natural and pharmaceutical compounds, the ability to oxidize a C-H bond in the presence of nitrogen is 
necessary for a robust and synthetically useful methodology.  Figure 3 outlines the main challenges that 
amines present to this non-heme catalyst system.  First, nitrogen can ligate the metal central via free 
lone pairs, exemplified by the use of a tetra-dentate amine ligand scaffold (PDP).  This lone pair is 
present in many different amine motifs (Figure 3, A), and initial observations in our group have shown 
that under standard oxidation conditions, no conversion is observed in the presence of an amine.  This is 
presumably due to irreversible catalyst binding, which results in a coordinatively saturated iron center, 
and ultimately a dead catalyst for C-H oxidation chemistry.  A second challenge to overcome is a 
question of site-selectivity for the oxidation.  We have shown in our group that the electrophilic catalyst 
generally selects for electron-rich C-H bonds.  In the context of an amine, first principles would predict 
that oxidation should occur distal to the inductively electron-withdrawing nitrogen (Figure 3, B).  
However it is known that hyperconjugation of lone-pair containing nitrogen (and oxygen) functionality, 
through an n to σ* interaction, can weaken and activate adjacent α-hydrogens towards oxidation (Figure 
3, C).   
 
 In our efforts to develop a strategy for nitrogen-protection during oxidation, we first looked at a 
simple primary amine with an appended 3° C-H bond: isoamylamine.  When a single tert-
4 
 
butyloxycarbonyl (Boc) protective group is appended, 0% of the corresponding hydroxylated product is 
isolated (Table 1, entry 1).  Furthermore, no isolable amount of the starting material can be recovered, 
presumably due to substrate degradation via a boc-deprotection type pathway.  Alternatively, use of a 
highly electron-withdrawing p-nitrophenylsulfonyl group (Nosyl) again affords none of the desired 
hydroxylated product (entry 2).  In this case, a quantitative amount of the starting material can be 
recovered, suggesting catalyst ligation as opposed to N-deprotection.  Combing the two in a dual 
protection strategy (N-Boc-N-Nosyl) resulted in restored reactivity, yielding the corresponding amino-
alcohol 4 in 55% yield with 30% recovered starting material (entry 3).  Additionally, we found that a 
“single” protective group, 4-nitrophthalimide, was sufficient for productive oxidation, affording amino-
alcohol 5 in 57% yield and 27% recovered starting material.       
 
 Protection of 2° and 3° linear and cyclic amines presents a new challenge in that the dual-
protection strategy optimized for 1° amines is not possible.  For 2° amines, we hypothesize a single 
protective group would need to impart large steric or electronic interference between the amine and 
the catalyst, while 3° amines would require a similar modification for a reasonable probability of 
oxidation to occur.  In the case of piperidine, a cyclic 2° amine, a single Boc or Nosyl group would not be 
sufficient to afford reactivity (from trends in Table 1).  Instead we envisioned a di-alkylation strategy 
using a p-nitrobenzyl group that would lead to the corresponding ammonium complex (Figure 4, A).  
Although literature precedence existed for alkylation using a simple benzyl halide5, the required p-
nitrobenzyl variant was unable to undergo the second alkylation and was therefore not able to be 
tested.  A similar ‘alkylation-to-ammonium’ strategy was implemented for a 3° amine, this time using 
methyl Iodide, followed by counterion metathesis (Figure 4, B).  While neither the original amine nor the 
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ammonium iodide productively converted to hydroxylated product, metathesis to the SbF6
- salt followed 
by oxidation did afford the corresponding amino-alcohol (20-40% yields).  Due to the extremely polar 
nature of the ammonium salt, isolation on silica was inconsistent and challenging, and yields varied 
dramatically.  Another potential problem with this method is the deprotection.  Although removal of a 
single methyl group from the ammonium salt is precedentedx, reaction conditions are harsh and yields 
are typically low. 
 
 While standard covalent modification appeared to be ineffective for these challenging amine 
classes, we hypothesized that complexation of the lone-pair via Lewis-type interactions could be a viable 
alternative.  We became interested in boron due to its Lewis-acid nature and high aza-philicity7.  The 
empty p-orbital on tri-substituted boron compounds is known to interact with Lewis-basic lone pairs, 
especially those of amines.  Furthermore, the three R groups can be a variety of substituents of varying 
steric and electronic properties (Figure 4, C).  MIDA boronates exemplify this type of attenuation of 
reactivity through similar interactions.  Developed by the Burke group for iterative cross-coupling 
reactions8, the nitrogen lone-pair of the MIDA group donates into the empty p-orbital on boron, 
preventing transmetallation until the MIDA group is hydrolyzed and the empty p-orbital re-exposed8.  In 
the case of a C-H oxidation system, complexation of a highly electron-deficient boron source (BF3) to an 
amine would hopefully effect a similar outcome, whereby the nitrogen would remain complexed to the 
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boron source rather than the metal center of the catalyst.  Additionally, use of a highly electron-
withdrawing source of boron would also limit the probability of α-oxidation to the hemiaminal. 
 Historically, BF3 has been used as an in-situ Lewis-acid activator for various reactions
7.  However, 
it is atypical that the complex itself is isolated, purified, and used as a reagent.  For our purposes, 
isolation of the pure complex was necessary in order for testing under the oxidation conditions such that 
no free amine remained to inhibit catalyst activity.  Table 2 outlines efforts towards nitrogen protection 
with BF3.  1° amines are successfully complexed and purified, producing complexes 6a and 7a in useful 
yields of the pure, isolated complex (entries 1 and 2).  Similarly, 2° cyclic amines also afford the 
corresponding complexes 8a and 9a in excellent yields, and are stable to silica gel chromatography 
(entries 3 and 4).  In the case of diamine 9, use of limiting BF3 (1 equiv) resulted in complete selectivity 
for complexation at the 2° nitrogen, with no bis-BF3 complex observed by TLC or upon isolation (entry 4).   
 
When two equivalents of BF3 are used, however, no amount of bis-complexed 10a can be 
isolated (entry 5).  Similarly, complexation of 3° amine 11 resulted in conversion by TLC to the presumed 
N-BF3 complex 11a.  However upon attempts to isolate and purify the complex, degradation to the free 
amine was immediate and unavoidable (entry 6).  In the case of a 3° aryl amine (pyridine, 12), a 47% 
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yield of the pure complex was achieved via crystallization and filtration.  (When subjected to silica gel 
chromatography, the complex readily dissociated).  Complexation with quinuclidine 13 afforded 87% of 
complex 13a, also isolated via crystallization/filtration.  As with 12a, this complex was unstable to 
normal silica gel, but was found to be stable to the less-acidic Florisil.  From these results, it is apparent 
that 1° and 2° amines are synthetically ideal substrates for BF3 complexation/protection, while isolation 
and purification issues prevent this methodology from applying generally to 3° amines. 
With several BF3-complexed amines available, we began testing their stability to oxidation 
(Table 3).  Oxidation of 4-isoamyl piperidine-BF3 yielded amino-alcohol 14 (as the BF3 complex) in 45% 
yield, with 40% recovered starting material (entry 1).  The high recovered starting material and overall 
mass balance of this reaction suggest a high level of site selectivity, even in the presence of 6 labile C-H 
bonds.  As predicted, no amount of hemiaminal was detected in the reaction due to the extremely 
electronegative nature of the complex, with oxidation deferred several bonds away from the N-BF3 
complex.  Further evidence of this can be seen in entry 2, whereby oxidation of n-hexylamine-BF3 
yielded a modest 25% of ketone 15 (5 carbons removed from the nitrogen) with 44% of the starting 
material recovered (entry 2).  The only isolable side-product of this reaction is oxidation at site 2, 
resulting in 8% of ketone 16, with negligible amounts of combined oxidation at the 3 interior carbons.  
Since methylene oxidation is typically more difficult for this catalyst than methine C-H bonds, we also 
tested isoamylamine-BF3 (entry 3).  Although a low mass balance was achieved overall, the 
corresponding amino-alcohol was produced in 22% yield, with 19% recovered starting material (entry 3).  
Comparison of the yields of entries 1 and 3 further demonstrates the electronic influence of the BF3 
group, where oxidation 3 carbons removed is significantly inhibited compared to 7 carbons away.  This is 
further exemplified by oxidation of quinuclidine-BF3 18 (2 carbons distant), where no oxidation products 
are observed, and >90% of the starting material can be recovered (entry 4).   
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1.3 CONCLUSIONS 
Overall, the use of BF3 as a protecting group for nitrogen functionality successfully allows 
oxidation in the presence of 1° and 2° amine complexes.  While 1° amines are still better suited for the 
dual-protection strategy (Table 1), we have demonstrated the first successful oxidation of a secondary 
amine-containing substrate under our standard oxidation conditions.  Furthermore, classes such as 3° 
and aromatic amines remain a challenge for future protection solutions, with the ultimate goal being 
oxidation of complex alkaloid natural products. 
1.4 EXPERIMENTAL SECTION 
General Information. The following commercially obtained reagents for the C-H oxidation reaction were 
used as received: 50% H2O2 (Sigma-Aldrich), AcOH (Mallinckrodt), CH3CN (Sigma-Aldrich). All oxidation 
reactions were run under air with no precautions taken to exclude moisture. Thin-layer chromatography 
(TLC) was conducted with E. Merck silica gel 60 F254 precoated plates (0.25 mm) and visualized with UV, 
potassium permanganate, ceric ammonium molybdate, or Ninhydrin stains. Flash column 
chromatography was performed using EM reagent silica gel 60 (230-400 mesh). 1HNMR spectra were 
recorded on a Varian Unity-500 (500 MHz) narrow bore spectrometer and are reported in ppm using 
solvent as an internal standard (CDCl3 at 7.26 ppm). Data reported as: s = singlet, d =doublet, t = triplet, 
q = quartet, m = multiplet, b = broad, app = apparent; coupling constant(s) in Hz; integration. Proton-
decoupled 13C-NMR spectra were recorded on a Varian Unity-500 (125MHz) spectrometer and are 
reported in ppm using solvent as an internal standard (CDCl3 at 77.16 ppm).  
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(-)-2-(((S)-2-((S)-1-(pyridin-2-ylmethyl)pyrrolidin-2-yl)pyrrolidin-1-yl)methyl)pyridine (PDP Ligand). A 
200 mL round bottom flask was charged with a stir bar, (S,S)-2,2’-bispyrrolidine tartrate (S2) (1.0 equiv, 
4.0 g, 13.8 mmol) and H2O (30 mL), and CH2Cl2 (30 mL). Solid NaOH pellets (6.4 equiv, 3.53 g, 88.2 
mmol) were added, followed by 2-picolyl chloride·HCl (2.2 equiv, 4.97 g, 30.3 mmol). After 18 h stirring 
at room temperature, the reaction mixture was diluted with 1M NaOH. The aqueous layer was extracted 
with CH2Cl2 (3 x 50 mL), and the organic extracts were combined, dried over MgSO4, and concentrated 
in vacuo. The crude ligand thus obtained was purified by silica gel chromatography (5% MeOH/ 
2%NH4OH/CH2Cl2) and the collected fractions were combined, washed with 1M NaOH, dried over 
MgSO4, and concentrated in vacuo to provide 2.8 g (8.6 mmol) of (S,S’)-PDP in 62% isolated 
yield. 1H NMR (400 MHz, CDCl3) δ 8.49 (dd, J = 0.8, 4.8 Hz, 2H), 7.60 (dt, J = 2.0, 7.8 Hz, 2H), 7.39 (d, J = 
7.6 Hz, 2H), 7.11 (dd, J = 5.2, 6.0 Hz, 2H), 4.19 (d, J = 14.0 Hz, 2H), 3.49 (d, J = 14.4 Hz, 2H), 2.99 (p, J = 4.4 
Hz, 2H), 2.79 (m, 2H), 2.22 (appq, J = 8.4 Hz, 2H), 1.77-1.64 (m, 8H); 13C NMR (100 MHz, CDCl3) δ 160.4, 
148.8, 136.3, 122.7, 121.6, 65.3, 61.1, 55.3, 25.9, 23.5; IR (film, cm-1): 2960, 2920, 2872, 2806, 1588, 
1570, 1474, 1431, 1366, 1212, 1150, 1120, 1046, 993, 931, 897, 759; HRMS (ESI) m/z calc’d C20H27N4 
[M+H]+: 323.2236, found 323.2239; [α]25 D -94.6° (c 1.0 MeOH). 
 
 
[Fe(S,S-PDP)(CH3CN)2](SbF6)2 (1) 
A 50-mL round bottom flask was charged with (S,S)-PDP ligand (1.095 g, 3.39 mmol, 1 equiv.) 
and 20 mL CH3CN. Fe(II)Cl2•4H2O (675 mg, 3.39 mmol, 1 equiv) was added to the stirring solution at 
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room temperature under a nitrogen atmosphere. Immediately upon adding the Fe source to the (S,S)-
PDP solution, precipitation of a bright orange solid was observed. Upon stirring for 24 h, diethyl ether 
was added to the solution to precipitate out the remainder of the complex. The solvent was decanted 
out of the flask via pipette and the solids were washed thoroughly with ether, and dried under a 
nitrogen stream for 4 hours to yield Fe(S,SPDP)(Cl)2 (1.29 g, 2.67 mmol, 79% yield): HRMS (ESI) m/z 
calc’d  20H26N4ClFe [M-Cl]+: 413.1195, found 413.1201.  
A flame dried 250-mL flask was charged with 608 mg of solid Fe(S,S-PDP)(Cl)2 (1.35 mmol, 1 
equiv.) suspended in CH3CN (17 mL) under nitrogen. Silver hexafluoroantimonate (AgSbF6, 930 mg, 2.71 
mmol, 2 equiv.) was weighed under an inert argon atmosphere and then added to the vigorously stirred 
heterogeneous mixture. The flask was covered with aluminum foil to protect the silver salts from light. 
After 16-24 hours, the reaction was filtered through Celite ® and concentrated under vacuum. The 
purple solid was redissolved in CH3CN, filtered through a 0.2μm Acrodisc ® LC PVDF filter (HPLC 
certified), and concentrated. The purple residue was redissolved in CH3CN and the 
filtration/concentration procedure was repeated two more times to ensure no silver salts remained. The 
purple solid obtained was dried under a nitrogen stream for 5 hours to yield [Fe(II)(S,S-PDP)(CH3CN)2] 
(SbF6)2 (4) (2.7 g, 3.08 mmol, quantitative yield). 
General Procedure A (Iterative Addition Oxidation): A 40 mL screwtop vial was charged with the 
following: (R,R)-1 (23.3 mg, 0.025 mmol, 5 mol%), substrate ( 0.5 mmol, 1.0 equiv.), CH3CN (0.75 mL, 
0.67 M), and AcOH (15.0 mg, 0.25 mmol, 50 mol%) and a magnetic stir bar. The vial was placed on a stir 
plate and stirred vigorously at room temperature. A solution of H2O2 (50 wt%, 36.8 μL, 0.6 mmol, 1.2 
equiv.) in CH3CN (4.5 mL) was added dropwise via syringe over ca. 45-75 seconds. The first drop of 
peroxide solution instantly changes the reaction mixture from a reddish-purple color to a dark orange 
which quickly disspates to a light yellow/brown. As more peroxide is added, this yellow/brown color 
slowly changes to a darker amber color. Significant decreases in yield were noted when the peroxide 
solution was added rapidly. No significant difference in yield was noted if the dropwise addition 
exceeded 75 seconds (up to 150 seconds). After ca. 10 minutes, a solution of 1 (23.3 mg, 0.025 mmol, 5 
mol%), AcOH (15 mg, 0.25  mmol, 50 mol%), in CH3CN (0.5 mL) was added via pipette. This was followed 
by H2O2 (50 wt%, 36.8 μL, 0.6 mmol, 1.2 equiv.) in CH3CN (4.5 mL) added dropwise over ca. 45-75 
seconds. A third addition was done in the same manner for a total of 15 mol%, 1.5 equiv. AcOH, and 3.6 
equiv. H2O2. Each addition was allowed to stir for 10 minutes, for a total reaction time of 30 minutes. 
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Tert-butyl (3-hydroxy-3-methylbutyl)((4-nitrophenyl)sulfonyl)carbamate (4).  Synthesis of compound 
(4) was achieved via General Procedure A (above).  Reaction was concentrated and taken up in minimal 
dichloromethane, then purified via flash column chromatography to afford the title compound in 55% 
overall yield.  1H NMR (500 MHz, Chloroform-d) δ 8.4 (d, J = 8.8 Hz, 2H), 8.1 (d, J = 8.8 Hz, 2H), 4.1 – 3.9 
(m, 2H), 2.0 – 1.9 (m, 2H), 1.4 (s, 9H), 1.3 (s, 6H). 
 
2-(3-hydroxy-3-methylbutyl)-5-nitroisoindoline-1,3-dione (5). Synthesis of compound (5) was achieved 
via General Procedure A (above). Reaction was concentrated and taken up in minimal dichloromethane, 
then purified via flash column chromatography to afford the title compound in 57% overall yield. 1H 
NMR (500 MHz, Chloroform-d) δ 8.7 – 8.6 (m, 1H), 8.6 – 8.6 (m, 1H), 8.6 (dd, J = 8.1, 2.0 Hz, 1H), 8.1 – 
8.0 (m, 1H), 4.0 – 3.9 (m, 2H), 1.9 – 1.8 (m, 2H), 1.3 (s, 6H), 8.6 – 8.6 (m, 1H). 
General Procedure B (N-BF3 protection). To a flame-dried round-bottom flask with a teflon stir bar was 
added substrate (1.0 equivalents), and diluted with dry THF (from SDS, 1M).  The solution was cooled to 
-78◦C and Boron Trifluoride Diethyl Etherate (BF3-OEt2, 1.1 equivalents) was added dropwise.  The 
reaction was warmed to 0◦C and stirred for 30min-1 hour, monitoring by Thin Layer Chromatography 
until complete consumption of the substrate was achieved. In some cases, an excess of BF3-OEt2 was 
added (in 0.2 equivalent successive proportions) to achieve full conversion.  Upon completion, the 
reaction was concentrated down to dryness.  Purification was achieved by either recrystallization from 
appropriate solvent mixtures, or in some cases via flash column chromatography (although some N-BF3 
complexes were not stable to Silica gel).      
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N-(trifluoroboron)-3-methylbutan-1-amine (7a). N-BF3 complex 7a was synthesized via General 
Procedure B.  Purification was achieved via plugging the crude reaction over silica gel (1 x 3in plug, 100% 
Ethyl Acetate eluent, ~100mL) to yield the product as a white solid in 93% yield.  1H NMR (500 MHz, 
Chloroform-d) δ 3.9 (s, 2H), 3.0 – 2.9 (m, 2H), 1.7 (dt, J = 13.3, 6.7 Hz, 1H), 1.5 (q, J = 7.4 Hz, 2H), 0.9 (d, J 
= 6.6 Hz, 6H).  
 
N-(trifluoroboron)-4-(4-methylpentyl)piperidine (8a). N-BF3 complex 8a was synthesized via General 
Procedure B.  Purification was achieved via plugging the crude reaction over silica gel (1 x 3in plug, Ethyl 
Acetate eluent, ~100mL) to yield the product as a white solid in 94% yield. 1H NMR (500 MHz, 
Chloroform-d) δ 3.8 (s, 1H), 3.4 – 3.4 (m, 2H), 2.8 – 2.6 (m, 2H), 1.9 (d, J = 14.1 Hz, 3H), 1.6 – 1.4 (m, 1H), 
1.5 – 1.4 (m, 1H), 1.3 – 1.2 (m, 4H), 1.2 (ddd, J = 10.0, 6.8, 3.1 Hz, 3H), 0.9 (d, J = 6.6 Hz, 6H). 
 
N-(trifluoboron)-2-methyl-5-(piperidin-4-yl)pentan-2-ol (14).  Hydroxylation of compound 8a was 
achieved via General Procedure A (on a 0.2mmol scale).  The crude reaction was concentrated and 
purified via silica gel chromatography (4% MeOH in DCM eluent) to afford 21mg (44%) of 14 as a white 
solid. 1H NMR (500 MHz, Chloroform-d) δ 3.8 (s, 1H), 3.4 (d, J = 13.2 Hz, 2H), 2.7 (q, J = 12.1 Hz, 2H), 2.0 – 
1.9 (m, 3H), 1.5 – 1.4 (m, 3H), 1.4 – 1.3 (m, 2H), 1.2 (d, J = 15.5 Hz, 9H). 
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N-(trifluoroboron)-4-amino-2-methylbutan-2-ol (17). Hydroxylation of compound 7a was achieved via 
General Procedure A (on a 0.2mmol scale).  The crude reaction was concentrated and purified via silica 
gel chromatography (2% to 4% MeOH in DCM eluent) to afford 7mg (22%) of 17 as a white solid. 1H NMR 
(500 MHz, Chloroform-d) δ 4.8 (s, 2H), 3.2 (s, 2H), 1.8 – 1.7 (m, 2H), 1.3 (s, 6H). 
 
1.5 REFERENCES 
____________________________ 
1 (a) Dick, A. R.; Sanford, M. S. Tetrahedron, 2006, 62, 2439-2463. (b) Young, A.J.; White, M.C. J. Am. 
Chem. Soc., 2008, 130, 14090-14091. (c) Chen, M.S.; White, M.C. Science, 2007, 318, 783-787. 
(d) Hartwig, J.F.; et.al, J. Am. Chem. Soc., 2006, 128, 13684-13685.  
2 “National Library of Medicine”, National Institutes of Health, <http://www.nlm.nih.gov/>. 
3 Chen, M.S.; White, M.C. Science, 2007, 318, 783-787. 
4 Tang, K. X.; Guo, B. H.; Kai, G. Y.; Jin, H. B. Afr. J. Biotechnol. 2006, 5, 15-20. 
5 Kim, Y. J.; Man, Kim, N. S.; Patil, P. S.; Ahn, K. D.; Kim, J.; and Kim, T. H. J. Applied Polymer Science, 2009, 
111, 1878-1883. 
6 Hutchins, R. O.; Dux, F. J. J. Org. Chem, 1973, 38, 1961-2. 
7 (a) Smith, C. H. Modern Plastics 1969, 46, 118.  (b) Chabanne, P. et. Al., J. App. Pol. Sci. 1993, 49, 685. 
(c) Contreras, R., et. Al.  Mag. Res. In Chem., 1993, 31, 189.  (d) Inorg. Chem. 2001, 40, 3243.  
8 Burke, M. et. Al., J. Am. Chem. Soc. 2007, 129, 6716. 
 
 
 
 
 
 
14 
 
CHAPTER 2 
APPLICATION TOWARDS AMINO ACID AND PEPTIDE OXIDATION, WITH FOCUS ON REACTIVITY AND 
SELECTIVITY TRENDS 
2.1 INTRODUCTION 
 Use of peptides in the pharmaceutical industry has greatly increased in recent years.  As of 2005, 
there were 40 marketed peptides worldwide, 270 in clinical phase testing, and over 400 in advanced 
pre-clinical trials.  Peptides have many advantages over small molecule drug treatments such as high 
activity and target specificity, minimal drug-drug interactions, low tissue accumulation, and high 
biological/chemical diversity1.  However many limitations also remain, low oral availability (must dose 
via injection), low biological stability, solubility and biological clearing problems, and ultimately 
challenging and costly syntheses1.  The high promise of peptides as pharmaceutical agents has led our 
group to be interested in developing methods to simplify the synthetic process via direct oxidation and 
subsequent diversification using our non-heme iron oxidation methodology.  
Utilizing principles from our efforts towards nitrogen tolerance for our non-heme iron catalyst, 
we began to evaluate direct oxidation of amino acids and small peptides, the major challenge being 
dense functionality, of which Nitrogen moieties are a primary concern.  All amino acids contain amine 
and carboxylic acid backbones, with a variety of other functionality depending on the side-chain 
substituents.  In the context of small peptides, we were also aware of the possibility of amide oxidation 
to the corresponding N-oxides, a prevalent oxidative pathway with small molecule oxidants such as 
dimethyldioxirane (DMDO) and trifluoromethyldioxirane (TFDO)2 (Figure 5, A). Other metal-based 
methods have been developed in the Sames group to effect similar amino-acid aliphatic oxidations using 
platinum3, however substrate scope is highly limited, and selectivities and overall yields are less than 
synthetically useful.   
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2.2 RESULTS AND DISCUSSION 
Optimization of backbone (amine and carboxylic acid) protecting groups was first evaluated.  
Starting with Leucine methyl ester, several common N-protecting groups were tested under the 
standard oxidation conditions for product conversion.  When either an N-acetyl or N-Boc group was 
appended, no conversion was observed whatsoever (Figure 5, B).  We then attempted a dual protection 
strategy using the N-Boc-N-Nosyl variant, which yielded 20% of the desired lactone.  Due to its highly 
electron-withdrawing nature, we attempted the mono-protected N-nosyl leucine, which not only 
underwent productive oxidation, but produced an increased lactone yield of 26% with 55% recovered 
starting material.  Although previously a single nosyl group was not sufficient to allow productive 
oxidation (Table 1, entry 2), we hypothesize that the electron-withdrawing nature of the adjacent ester 
moiety decreased electron density at Nitrogen enough to prevent catalyst binding.  At the C-terminus, 
we were aware that carboxylic acids act as directing groups for oxidation.  We then tested the necessity 
of the C-terminal ester group.  To our surprise, the N-nosyl amino acid readily decarboxylated under the 
standard oxidation conditions (Figure 5, C).  (Although the mechanism of this decomposition is currently 
unknown, small amounts of α-oxidation suggest that oxidation occurs first at the α-C-H bond, which 
promotes decarboxylation). From these studies, N-nosyl amino esters were selected as the standard 
motif for amino acid and peptide protection during non-heme oxidation.     
   With a general protection strategy developed, we focused on single amino acid oxidation, first 
assessing which residues are stable to the oxidation conditions (Table 4).  The methyl esters of both 
Aspartic and Glutamic Acid (19 and 20) were both re-isolated in >95% (entries 1 and 2).  In the case of 
Serine and Threonine, acetate protection of the free alcohol afforded stable compounds, as >95% of 
both 21 and 22 were recovered (entries 3 and 4).  Lysine is a special case in that it has an amine-
containing side-chain as well as the α-amine.  Considering the ε-amine (side chain) does not benefit 
from the electron withdrawing properties of the ester, it was necessary to use the dual protection 
strategy discussed above.  In order to avoid lengthy orthogonal protection strategies, bis-4-
nitrophthalimide methyl ester 33 was tested, and recovered in 90% after oxidation (entry 5).  
Considering BF3 protection was best utilized with cyclic, 2° amines, Proline was complexed and tested.  
Not surprisingly from our results above, Proline Methyl Ester-BF3 complex 24 was recovered in >95% 
after oxidation (entry 6).  Entries 7-10 show several derivatives of Phenylalanine with varying electron-
withdrawing substitution.  Protected difluorophenylalanine 25 was only recovered in 37% yield after 
oxidation, with the remainder of the mass balance going to unproductive and unisolable oxidation of the 
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phenyl ring (entry 7).  The tri-fluorinated variant, 26, showed a drastic improvement, with 77% 
recovered after oxidation (entry 8).  Although this number is low compared to entries 1-6, our hope is 
that the catalyst will select for more reactive C-H bonds of other residues when in the context of a small 
peptide (see below).  Although Fluorine is inductively electron withdrawing, it can also donate electron 
density via its lone pairs.  This is not the case, however, with nitro and trifluoromethyl groups, both of 
which are highly electron withdrawing substituents.  It is not surprising, then, that p-nitrophenylalanine 
27 and 3,5-bistrifluoromethylphenylalanine 28 were both recovered in >95% after oxidation (entries 9 
and 10).    
 
 Next we sought to apply our methodology to natural amino acids with oxidizeable functionality 
(Table 5).  Under slow addition (syringe pump) conditions, with elevated levels of hydrogen peroxide 
and acetic acid (9.0 and 1.0 equivalents, respectively) as optimized conditions, Leucine methyl ester 29 
was oxidized to the corresponding lactone in 44% yield, with 25% recovered starting material (entry 1).  
Use of the tert-butyl ester at the C-terminus of Leucine (37) prevents spontaneous lactonization, and the 
free alcohol was isolated in 48% yield with 24% recovered starting material (entry 2).  Valine methyl 
ester 30 undergoes oxidation in a similar fashion, yielding the free alcohol in 39% yield and 45% 
recovered starting material (entry 3).  In this case, formation of the 4-membered lactone is disfavored, 
and use of the tButyl ester was not necessary.  As expected, Valine suffers from slightly lower reactivity 
than Leucine, a consequence of the proximity to the electron-withdrawing backbone resulting in a more 
electron-deficient C-H bond.  The mass balance for oxidation of Valine is significantly higher than that of 
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Leucine as well, suggesting the isobutyl side chain of Leucine undergoes alternate or over oxidation not 
possible for the isopropyl moiety of Valine.   
 
 In recent years, there has been an increased interest in unnatural amino acid production and 
incorporation into pharmaceutical peptides.  Work by the Schulz groupx provoked an interest in a variety 
of linear aliphatic amino acids, with carbon chains ranging from 3-6 atoms long.  With multiple sites of 
potential oxidation available, selectivity becomes an important issue.  The sterics and electronics of the 
backbone were modified in an effort to influence the selectivity to produce a single ketone product in 
synthetically useful yields.  We first looked at n-Hexylglycine with a variety of protecting group 
combinations (Table 6, entries 1-4).  Under standard protection as the N-Nosyl Methyl ester, slow 
addition protocol afforded 19% of methyl ketone 33, while ketone formation at carbons 2 and 3 were 
isolated in similar yields to give an overall product distribution of 1.6 : 1.6 : 1 (entry 1). The tButyl ester 
(increased sterics) did not improve the yield of 34 (19%), however a small increase in selectivity was 
observed (1.9 : 1.5 : 1) (entry 2).  Addition of a second electron withdrawing group to the amine (N-
Nosyl-N-Boc methyl ester) afforded 35 in a slightly increased yield of 22% while maintaining similar 
selectivities (1.8 : 1.4 : 1) (entry 3).  A combination of the dual protection with the tButyl ester, 
somewhat surprisingly, yielded 36 in 19% yield and low selectivity of 1.6 : 1.4 : 1 (entry 4).  Shorter 
chains were also assessed.  N-Nosyl Norvaline methyl ester, under slow addition protocol, afforded 
ketone 37 in 17% yield, with 65% recovered starting material and no other isolable products (entry 5).  
Using elevated oxidant this yield could be optimized to 22% (entry 6).  Extension of the carbon chain to 4 
(Norleucine) afforded ketone 38 in a substantially higher yield of 35%, with 45% of the starting material 
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recovered (entry 7).  This was then re-subjected to the reaction conditions, and a combined yield of 44% 
of ketone 38 was obtained (entry 8).  Although elevated oxidant was used (entry 9), yield of the desired 
ketone did not increase (35%), and the overall mass balance was much lower with only 26% of the 
starting material recovered (entry 9).      
 
 Oxidation of amino acid residues in the context of dipeptides was also explored.  Combinations 
of Leucine or Valine with oxidatively stable residues were synthesized and tested under standard 
reaction conditions (Table 7).  Oxidation of Valine-Glutamic Acid dipeptides show increased reactivity 
with Valine at the N-terminus (39, 41% yield) versus the C-terminus (43, 18% yield) (entries 1 and 2).  
Although less dramatic, this trend held true for Leucine-Glutamic Acid dipeptides, affording 40 in 28% 
yield and 44 in 24% yield (entries 3 and 4).  An interesting feature of the Leucine-containing peptides is 
the markedly decreased reactivity in the context of a dipeptide versus that of the single amino acid 
oxidation.  Yields for N-terminal Valine (41%) match the result of mono-Valine oxidation, as expected 
(39%, table 5, entry 3).  While oxidation of mono-Leucine affords 44-48% of the oxidized product (Table 
5, entry 1 and 2), yield of N-terminal Lecuine oxidation in a peptide was significantly lower.  To assess 
whether Glutamic Acid was imparting electronic or steric hindrance of Leucine oxidation, we synthesized 
and tested the Alanine-containing analogs of each dipeptide in an effort to eliminate these effects with a 
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smaller, neutral side chain (entries 5-8).  Once again, N-terminal Valine was oxidized to 41 in a 42% yield, 
comparable to the single amino acid (39% yield), while C-terminal Valine remained less reactive, 
affording 45 in a 20% yield (entries 5 and 6).  Low reactivity for Leucine at the N-terminus continued to 
be problematic, affording 42 in 25% yield (entry 7), with the C-terminal residue yielding 20% of 46 (entry 
8).  These results rule out Glutamic Acid as the problem for low reactivity of Leucine in a peptide setting, 
and further studies will be required to determine the cause of differing reactivity.     
 
 Competition studies were also conducted in a dipeptide setting to determine selectivity 
between two oxidizable residues, noting differences in selectivity for oxidation at the C- vs. N-termini 
(Table 8).  Entry 1, oxidation of a Valine-Valine dipeptide, shows a clear preference for oxidation at the 
N-terminal residue, yielding 37% of the mono-hydroxylated product and 51% of the unoxidized starting 
material recovered.  The remaining material was isolated as a mixture of C-terminal hydroxylation and 
di-hydroxylation products (inseparable via chromatography), in a combined yield of 12%.  Hydroxylation 
at the C-terminus could be completely prevented by using the tert-butyl ester analog, however overall 
20 
 
reactivity was drastically decreased (entry 2).  While no C-terminal oxidation or di-hydroxylation 
products were observed, the N-terminal hydroxylated product was only produced in a 14% yield, with 
71% of the unoxidized starting material recovered.  This increase in selectivity can be attributed to 
increased steric bulk of the tert-butyl ester group.  The decreased overall reactivity, however, is less 
straightforward. We hypothesize that tert-butyl esters may not be compatible with the Lewis-acidic 
nature of the catalyst (currently under further investigation).  In the case of a Leucine-Leucine dipeptide, 
N-terminal residue preference was less dramatic, although still apparent.  Oxidation at the N-terminal 
residue yielded 27% hydroxylation product, while a mixture of C-terminal and di-hydroxylated products 
were isolated in less than 20% yield, with 47% of unoxidized starting material recovered (entry 3).  In 
this case, the tert-butyl ester was used to prevent lactonization of the C-terminal hydroxylated product 
(a spontaneous process that occurs when the methyl-ester analog is used).  This was done to provide 
isolation of the hydroxyl-product for direct comparison to the N-terminal residue, as well as to promote 
an increased selectivity for oxidation at the N-terminal residue by increased steric bulk at the C-
terminus.  While the yield of the N-terminal product was less than that of the Valine-Valine analog, the 
overall mass balance was similarly high.  The decreased yield, then, can be attributed to the decrease in 
selectivity. We hypothesize that this is due to the increased distance of the reactive methine proton 
from the steric and electronic influence of the peptide backbone for the Leucine side chain versus that 
of a Valine. 
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Next we looked at Proline, which was found to have unique reactivity under the oxidation 
conditions (to form the hemiaminal). We continued our competition studies by synthesizing several 
dipeptides with Proline at the N-terminus, and another oxidizable residue at the C-terminus (Table 9).  
To our delight, we saw high selectivity for Proline oxidation in the presence of known oxidizable 
residues, however overall yields were not optimal.  In entries 1 and 2, an aliphatic residue was placed at 
the C-terminus.  In the case of Proline-Leucine, hemiaminal 50 was formed in 42% yield and 31% 
recovered starting material, with no oxidation at Leucine observed (entry 1).  For nor-Valine (containing 
a methylene active site, entry 2), oxidation to hemiaminal 51 was achieved in 37%, with 31% recovered 
starting material and no observed oxidation of the aliphatic side-chain.  We then turned our attention to 
aromatic-containing residues, which are typically incompatible with the oxidative conditions unless 
highly electron deficient.  A triflate-protected Tyrosine residue survived and yielded hemiaminal 52 in a 
slightly-decreased 20% yield with 43% recovered starting material (entry 3).  This is not surprising, as the 
aryl group is only slightly electron-deficient; yet still proving that oxidation to the hemiaminal is a highly 
favorable process.  When the aryl group is neutral, however, as in the case of a Phenylalanine residue, 
the majority of the material is converted to the quinone analog 53 by aryl oxidation (entry 4).  This 
material was isolated as a mixture of the quinone and hemiaminal-quinone 54 (di-oxidized product) in a 
25% yield, in a 95:5 ratio.  Therefore only about 1% of the overall process produced hemiaminal product, 
and oxidation to the hemiaminal was only effected after the quinone was formed. From this we see that 
although hemiaminal formation is a favorable process, oxidation of electron-rich aryls will still occur 
selectively under the reaction conditions.  Further studies will also need to be conducted, if possible, to 
improve the reactivity of these proline dipeptides in order to achieve synthetic utility.    
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 On the subject of oxidative selectivity within a peptide moiety, further studies are ongoing in 
our group.  At this point, only dipeptide structures have been tested for selectivity, differentiating 
exclusively between the C- and N- termini.  However, in longer peptide structures, internal residues are 
flanked by two amide moieties, as opposed to an amine and amide (N-terminus) or and amide and an 
ester (C-terminus), overall leading to a third electronic environment (Figure 6, A). A series of tripeptide 
oxidation studies will need to be conducted in order to flesh out full selectivity rules for longer peptide 
chain oxidations.  To test this, tripeptides will be synthesized that contain a terminal and internal 
oxidatively susceptible residue, with the alternate terminus containing and oxidatively stable residue 
(Figure 6, B).  By comparing a single terminus to a single internal residue and using 2 separate 
tripeptides, we can simplify purification of oxidation product mixtures while still obtaining useful 
selectivity information.   
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2.3 CONCLUSIONS 
 Reactivity and selectivity trends among various amino-acid residues were explored as both 
single amino-acids and multi-residue small peptides.  Amino acids were grouped based on oxidative 
susceptibility and oxidative stability, with protecting group schemes for incompatible side-chain motifs 
being developed to allow for productive oxidation.  Selectivity studies within a dipeptide motif were 
then conducted, assessing trends such as (1) relative head-to-head reactivity between various residues, 
(2) relative reactivity based on location within a peptide setting, and (3) relative selectivity trends of 
various sites within a single residue.  Distinct evidence was found to favor oxidation at the N-terminus 
preferentially to that of the C-terminus, while highly activated Aryl and Aza-cyclic moieties were found 
to be much more reactive than electron-poor (non-reactive) or aliphatic (moderately reactive) side 
chains.  Interestingly, reactivity trends sometimes differed between a single-residue setting and within 
the context of a peptide, such as the case for Leucine, while other times this disparity was not apparent 
(as with Valine).  Other anomalies include the highly reactive Proline residue, favoring hemiaminal 
formation that is not prevalent in the analogous pyrrolidine motif.   
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2.4 EXPERIMENTAL SECTION 
General Information. The following commercially obtained reagents for the C-H oxidation reaction were 
used as received: 50% H2O2 (Sigma-Aldrich), AcOH (Mallinckrodt), CH3CN (Sigma-Aldrich). All oxidation 
reactions were run under air with no precautions taken to exclude moisture. Thin-layer chromatography 
(TLC) was conducted with E. Merck silica gel 60 F254 precoated plates (0.25 mm) and visualized with UV, 
potassium permanganate, ceric ammonium molybdate, or Ninhydrin stains. Flash column 
chromatography was performed using EM reagent silica gel 60 (230-400 mesh). 1HNMR spectra were 
recorded on a Varian Unity-500 (500 MHz) narrow bore spectrometer and are reported in ppm using 
solvent as an internal standard (CDCl3 at 7.26 ppm). Data reported as: s = singlet, d =doublet, t = triplet, 
q = quartet, m = multiplet, b = broad, app = apparent; coupling constant(s) in Hz; integration. Proton-
decoupled 13C-NMR spectra were recorded on a Varian Unity-500 (125MHz) spectrometer and are 
reported in ppm using solvent as an internal standard (CDCl3 at 77.16 ppm). 
General Procedure C (Iron C-H Oxidation  Slow Addition Protocol).  25 mol% catalyst 1: A 40 mL 
screwtop vial was charged with the following: substrate (0.5 mmol, 1.0 equiv), CH3CN (1.0 mL, 0.5 M), 
and AcOH (15.0 mg, 0.25 mmol, 0.5 equiv) and a magnetic stir bar. The vial was placed on a stir plate 
and stirred vigorously at room temperature while open to ambient atmosphere. A 1.0 mL glass syringe 
was charged with a solution of Fe(PDP) 1 catalyst (116.5 mg, 0.125 mmol, 25 mol %) in CH3CN (0.625 mL, 
0.2 M) and loaded into a syringe pump set with an addition rate of 0.5 mL/1 h (0.0083 mL/min). A 10 mL 
glass syringe was charged with a solution of H2O2 (50 wt % in H2O, 170 μL, 2.5 mmol, 5.0 equiv) in CH3CN 
(6.25 mL, 0.4 M) and loaded into a syringe pump set with an addition rate of 5 mL/1 h (0.083 mL/min). 
Both syringes were equipped with 26G needles and directed into the center of the uncapped vial; 
precautions should be taken not to touch the sides. The two additions were initiated simultaneously and 
both Fe(PDP) 1 catalyst and H2O2 were added to the reaction vial over the course of 75 min. The crude 
mixture was concentrated via rotary evaporation to a minimal amount of CH3CN and taken up in ethyl 
acetate.  Dry Silica was added, and the crude reaction was concentrated to dryness (adsorbed onto the 
silica gel) and purified by flash chromatography.  
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(S)-N-(trifluoroboron)-Proline-Methyl Ester (24). N-protected Proline (24) was synthesized via General 
Procedure B and subjected to the iterative addition oxidation (general procedure A).  Post-oxidation, the 
reaction was purified via flash column chromatography to yield >95% of recovered starting material. 1H 
NMR (500 MHz, Acetonitrile-d3) δ 5.7 (s, 1H), 4.1 – 4.0 (m, 1H), 3.8 (s, 3H), 3.3 (dd, J = 11.7, 6.0 Hz, 1H), 
3.1 – 3.0 (m, 1H), 2.3 (dt, J = 13.8, 7.9 Hz, 1H), 2.0 (td, J = 15.7, 7.0 Hz, 2H), 1.8 (dd, J = 14.0, 6.9 Hz, 1H). 
 
Methyl 3-(3,4-difluorophenyl)-2-((4-nitrophenyl)sulfonamido)propanoate (25).  Compound 25 was 
subjected to General Procedure A.  The crude reaction was concentrated and purified via flash column 
chromatography yielding 37% of the starting material recovered, with loss of 63% of the remaining mass 
balance. 1H NMR (500 MHz, Chloroform-d) δ 8.4 – 8.2 (m, 2H), 8.0 – 7.8 (m, 2H), 7.0 (dt, J = 10.3, 8.2 Hz, 
1H), 6.9 (ddd, J = 10.3, 7.3, 2.3 Hz, 1H), 6.9 – 6.8 (m, 1H), 5.4 (d, J = 8.8 Hz, 1H), 4.2 (ddd, J = 8.9, 6.2, 4.9 
Hz, 1H), 3.6 (s, 3H), 3.1 (dd, J = 14.0, 5.4 Hz, 1H), 3.0 (dd, J = 14.0, 6.7 Hz, 1H).  
 
Methyl 2-((4-nitrophenyl)sulfonamido)-3-(3,4,5-trifluorophenyl)propanoate (26).  Compound 26 was 
subjected to General Procedure A.  The crude reaction was concentrated and purified via flash column 
chromatography yielding 77% of the starting material recovered, with loss of 23% of the remaining mass 
balance. 1H NMR (500 MHz, Acetonitrile-d3) δ 8.3 (d, J = 8.9 Hz, 2H), 7.9 (d, J = 8.9 Hz, 2H), 6.9 (dd, J = 
9.0, 6.6 Hz, 2H), 6.5 – 6.4 (m, 1H), 4.2 (td, J = 9.4, 4.7 Hz, 1H), 3.6 (s, 3H), 3.1 (dd, J = 14.2, 4.6 Hz, 1H), 2.8 
(dd, J = 14.2, 9.8 Hz, 1H). 
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Methyl 3-(4-nitrophenyl)-2-((4-nitrophenyl)sulfonamido)propanoate (27).  Compound 27 was 
subjected to General Procedure A.  The crude reaction was concentrated and purified via flash column 
chromatography yielding >95% of the starting material recovered. 1H NMR (499 MHz, Acetonitrile-d3) δ 
8.2 (d, J = 8.9 Hz, 2H), 8.0 (d, J = 8.7 Hz, 2H), 7.8 (d, J = 8.9 Hz, 2H), 7.3 (d, J = 8.7 Hz, 2H), 6.5 (d, J = 9.7 
Hz, 1H), 4.3 (q, J = 5.0 Hz, 1H), 3.6 (s, 3H), 3.2 (dd, J = 14.0, 4.9 Hz, 1H), 3.0 (dd, J = 14.0, 10.0 Hz, 1H). 
 
Methyl 3-(3,5-bis(trifluoromethyl)phenyl)-2-((4-nitrophenyl)sulfonamido)propanoate (28). Compound 
28 was subjected to General Procedure A.  The crude reaction was concentrated and purified via flash 
column chromatography yielding >95% of the starting material recovered. 1H NMR (500 MHz, 
Acetonitrile-d3) δ 8.2 (d, J = 8.9 Hz, 2H), 7.8 (d, J = 8.9 Hz, 3H), 7.8 (s, 2H), 6.5 (d, J = 9.6 Hz, 1H), 4.3 (td, J 
= 9.8, 4.8 Hz, 1H), 3.6 (s, 3H), 3.3 (dd, J = 14.1, 4.7 Hz, 1H), 3.0 (dd, J = 14.1, 10.0 Hz, 1H). 
 
(S)-N-(5,5-dimethyl-2-oxotetrahydrofuran-3-yl)-4-nitrobenzenesulfonamide (29a). Compound 29 was 
subjected to General Procedure C (Slow Addition oxidation).  The crude reaction was concentrated and 
purified via silica gel chromatography to yield the title compound as a white solid in 44% yield, with 25% 
of the starting material recovered.  1H NMR (500 MHz, Chloroform-d) δ 8.39 (d, J = 8.7 Hz, 2H), 8.13 (d, J 
= 8.8 Hz, 2H), 5.68 (s, 1H), 4.30 (dd, J = 11.6, 8.7 Hz, 1H), 2.61 (dd, J = 12.8, 8.7 Hz, 1H), 2.04 (t, J = 12.2 
Hz, 1H), 1.49 (s, 3H), 1.40 (s, 3H); 13C NMR (126 MHz, Chloroform-d) δ 173.4, 150.5, 145.6, 128.7, 124.7, 
83.7, 53.5, 43.0, 29.0, 27.1; IR (film, cm-1) 3302, 3109, 2980, 2939, 1770, 1606, 1531, 1454, 1351, 1308, 
1167, 1109, 1093, 922, 854, 739, 687, 617; HRMS (ESI) m/z calc’d for C12H14N2O6SNa [M+Na]+: 
337.0470, found 337.0469. 
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(S)-tert-butyl 4-hydroxy-4-methyl-2-((4-nitrophenyl)sulfonamido)pentanoate (30a). Compound 30 was 
subjected to General Procedure C (Slow Addition oxidation).  The crude reaction was concentrated and 
purified via silica gel chromatography to yield the title compound as a white solid in 48% yield, with 24% 
of the starting material recovered. 1H NMR (500 MHz, Chloroform-d) δ8.35 (d, J = 8.8 Hz, 2H), 8.08 (d, J = 
8.7 Hz, 2H), 5.92 (d, J = 7.2 Hz, 1H), 4.10 (td, J = 7.6, 4.9 Hz, 1H), 1.92 – 1.78 (m, 2H), 1.34 (s, 3H), 1.30 (s, 
9H), 1.28 (s, 3H); 13C NMR (126 MHz, Chloroform-d) δ 170.9, 150.2, 145.8, 128.9, 124.3, 83.0, 71.2, 54.7, 
44.1, 30.7, 29.1, 27.8; IR (film, cm-1) 3535, 3510, 3271, 3109, 2978, 2931, 1732, 1606, 1531, 1350, 1309, 
1255, 1153, 1092, 939, 856, 739, 685615; HRMS (ESI) m/z calc’d for C16H25N2O7S [M+H]+: 389.1382, 
found 389.1383. 
 
(S) -Methyl 3-hydroxy-3-methyl-2-((4-nitrophenyl)sulfonamido)butanoate (31a). Compound 31 was 
subjected to General Procedure C (slow addition oxidation).  The crude reaction was concentrated and 
purified via silica gel chromatography to yield the title compound as a white solid in 39% yield, with 45% 
of the starting material recovered. 1H NMR (500 MHz, Chloroform-d) δ 8.35 (d, J = 8.8 Hz, 2H), 8.05 (d, J 
= 8.8 Hz, 2H), 6.19 (d, J = 10.2 Hz, 1H), 3.85 (d, J = 10.2 Hz, 1H), 3.48 (s, 3H), 1.31 (s, 3H), 1.25 (s, 3H); 13C 
NMR (126 MHz, Chloroform-d) δ 171.0, 150.3, 145.7, 128.7, 124.4, 72.1, 63.5, 52.6, 26.9, 26.7; IR (film, 
cm-1) 3529, 3263, 3107, 2983, 2929, 1736, 1531, 1352, 1314, 1169, 1092, 856, 737, 617; HRMS (ESI) m/z 
calc’d for C12H17N2O7S [M+H]+: 333.0756, found 333.0756. 
 
Tert-butyl 2-((4-nitrophenyl)sulfonamido)-7-oxooctanoate (34). The title compound was isolated as a 
white foam following oxidation using General Procedure A (iterative addition protocol).  The major 
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product was isolated via purification using Medium Performance Liquid Chromatography to isolate this 
specific isomer in 19% overall yield.  The product ratio was 1.9 : 1.5 : 1 in favor of the methyl ketone (34) 
over the ethyl and propyl variants, respectively.  1H NMR (500 MHz, Chloroform-d) δ 8.3 (d, J = 8.6 Hz, 
2H), 8.0 (d, J = 8.6 Hz, 2H), 5.5 (d, J = 9.2 Hz, 1H), 3.9 – 3.8 (m, 1H), 2.4 (t, J = 7.2 Hz, 2H), 2.1 (s, 3H), 1.8 – 
1.7 (m, 1H), 1.7 – 1.5 (m, 3H), 1.4 (q, J = 7.5 Hz, 2H), 1.2 (s, 9H). 
 
Methyl 2-((4-nitrophenyl)sulfonamido)-4-oxopentanoate (37).  The title compound was isolated as a 
white semi-solid following oxidation using General Procedure A (iterative addition protocol).  The 
reaction was purified via flash chromatography on silica to yield the title compound as the only major 
product in 17% yield, with 65% of the starting material recovered.  1H NMR (500 MHz, Chloroform-d) δ 
8.4 (d, J = 8.8 Hz, 2H), 8.1 (d, J = 8.8 Hz, 2H), 5.8 (d, J = 8.4 Hz, 1H), 4.1 (dt, J = 8.5, 4.1 Hz, 1H), 3.6 (s, 3H), 
3.2 (dd, J = 18.4, 4.0 Hz, 1H), 3.1 (dd, J = 18.4, 4.1 Hz, 1H), 2.2 (s, 3H). 
 
(S,S)-Dimethyl (4-hydroxy-4-methyl-2-((4-nitrophenyl)sulfonamido)pentanoyl)glutamate (40).  Parent 
dipeptide Ns-Leu-Glu(OMe)-OMe was oxidized to the title compound using General Procedure C (slow 
addition protocol) with an elevated oxidant modification: H2O2 (9.0 equiv) and Acetic Acid (1.0 equiv).  
The reaction was concentrated and purified via flash column chromatography on silica gel to afford the 
title compound as a colorless oil in 28% yield (44% recovered starting material).  1H NMR (500 MHz, 
Chloroform-d) δ 8.3 (d, J = 8.8 Hz, 2H), 8.0 (d, J = 8.8 Hz, 2H), 5.5 (d, J = 8.9 Hz, 1H), 4.0 (td, J = 9.2, 4.5 
Hz, 1H), 3.5 (s, 3H), 2.7 (ddd, J = 18.6, 8.1, 6.1 Hz, 1H), 2.6 (dt, J = 18.6, 6.1 Hz, 1H), 2.2 (s, 3H), 2.2 – 2.1 
(m, 1H), 1.8 (ddt, J = 14.5, 9.5, 6.1 Hz, 1H). 
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(S,S)-Methyl (3-hydroxy-3-methyl-2-((4-nitrophenyl)sulfonamido)butanoyl)alaninate (41). Parent 
dipeptide Ns-Val-Ala-OMe was oxidized to the title compound using General Procedure C (slow addition 
protocol) with an elevated oxidant modification using H2O2 (9.0 equiv) and Acetic Acid (1.0 equiv).  The 
reaction was concentrated and purified via flash column chromatography on silica gel to afford the title 
compound as a white solid in 42% yield (15% recovered starting material). 1H NMR (500 MHz, 
Chloroform-d) δ 8.3 (d, J = 9.0 Hz, 2H), 8.1 (d, J = 8.8 Hz, 2H), 7.6 – 7.4 (m, 1H), 6.8 (s, 1H), 4.4 (dtd, J = 
8.2, 5.2, 2.6 Hz, 1H), 4.0 (d, J = 6.0 Hz, 1H), 3.7 (s, 3H), 3.7 (s, 3H), 2.4 – 2.2 (m, 2H), 2.1 – 2.0 (m, 1H), 1.9 
(ddd, J = 6.5, 4.8, 2.9 Hz, 3H), 1.3 (s, 3H), 1.1 (s, 3H). 
 
(S,S)-Methyl (4-hydroxy-4-methyl-2-((4-nitrophenyl)sulfonamido)pentanoyl)alaninate (42). Parent 
dipeptide Ns-Leu-Ala-OMe was oxidized to the title compound using General Procedure C (slow addition 
protocol) with an elevated oxidant modification using H2O2 (9.0 equiv) and Acetic Acid (1.0 equiv).  The 
reaction was concentrated and purified via flash column chromatography on silica gel to afford the title 
compound as a white solid in 25% yield (37% recovered starting material). 1H NMR (500 MHz, 
Chloroform-d) δ 8.3 (d, J = 8.6 Hz, 2H), 8.0 (d, J = 8.7 Hz, 2H), 6.6 (d, J = 7.9 Hz, 1H), 5.9 (d, J = 9.1 Hz, 1H), 
4.4 – 4.2 (m, 1H), 3.7 (s, 3H), 3.7 – 3.6 (m, 1H), 3.1 (s, 1H), 1.4 (s, 3H), 1.2 (d, J = 7.2 Hz, 3H), 1.1 (s, 3H). 
 
(S,S)-Methyl 5-((3-hydroxy-1-methoxy-3-methyl-1-oxobutan-2-yl)amino)-4-((4-
nitrophenyl)sulfonamido)-5-oxopentanoate (43). Parent dipeptide Ns-Glu(OMe)-Val-OMe was oxidized 
to the title compound using General Procedure C (slow addition protocol) with an elevated oxidant 
modification using H2O2 (9.0 equiv) and Acetic Acid (1.0 equiv).  The reaction was concentrated and 
purified via flash column chromatography on silica gel to afford the title compound as a white solid in 
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18% yield (49% recovered starting material). 1H NMR (500 MHz, Chloroform-d) δ 8.3 (d, J = 8.8 Hz, 2H), 
8.1 (d, J = 8.9 Hz, 2H), 7.2 (s, 1H), 6.5 – 6.4 (m, 1H), 4.3 (d, J = 8.8 Hz, 1H), 4.1 – 4.0 (m, 1H), 3.7 (s, 3H), 
3.7 (s, 3H), 2.9 (s, 1H), 2.6 – 2.3 (m, 2H), 2.3 – 2.1 (m, 1H), 2.1 – 2.0 (m, 1H), 1.9 (td, J = 7.8, 7.0, 2.6 Hz, 
1H), 1.2 (s, 3H), 1.0 (s, 3H). 
 
(S,S)-Methyl 5-((5,5-dimethyl-2-oxotetrahydrofuran-3-yl)amino)-4-((4-nitrophenyl)sulfonamido)-5-
oxopentanoate (44). ). Parent dipeptide Ns-Glu(OMe)-Leu-OMe was oxidized to the title compound 
using General Procedure C (slow addition protocol) with an elevated oxidant modification using H2O2 
(9.0 equiv) and Acetic Acid (1.0 equiv).  The reaction was concentrated and purified via flash column 
chromatography on silica gel to afford the title compound as a white solid in 24% yield (40% recovered 
starting material).  1H NMR (500 MHz, Acetone-d6) δ 8.4 (d, J = 8.8 Hz, 2H), 8.1 (d, J = 8.9 Hz, 2H), 7.8 (d, 
J = 7.6 Hz, 1H), 7.2 (d, J = 8.9 Hz, 1H), 4.8 – 4.6 (m, 1H), 4.1 (td, J = 8.7, 5.5 Hz, 1H), 3.6 (s, 3H), 2.5 – 2.4 
(m, 2H), 2.3 (dd, J = 12.4, 9.2 Hz, 1H), 2.0 – 2.0 (m, 1H), 2.0 – 1.8 (m, 2H), 1.4 (s, 3H), 1.4 (s, 3H). 
 
(S,S)-N-(5,5-dimethyl-2-oxotetrahydrofuran-3-yl)-2-((4-nitrophenyl)sulfonamido)propanamide (46). 
Parent dipeptide Ns-Ala-Leu-OMe was oxidized to the title compound using General Procedure C (slow 
addition protocol) with an elevated oxidant modification using H2O2 (9.0 equiv) and Acetic Acid (1.0 
equiv).  The reaction was concentrated and purified via flash column chromatography on silica gel to 
afford the title compound as a white solid in 20% yield (37% recovered starting material). 1H NMR (500 
MHz, Acetone-d6) δ 8.4 (d, J = 8.8 Hz, 2H), 8.1 (d, J = 8.9 Hz, 2H), 7.7 (d, J = 7.8 Hz, 1H), 7.2 (d, J = 8.5 Hz, 
1H), 4.7 (ddd, J = 11.4, 9.2, 7.7 Hz, 1H), 4.2 – 3.9 (m, 1H), 3.8 (s, 1H), 2.4 (dd, J = 12.3, 9.2 Hz, 1H), 2.0 – 
1.9 (m, 1H), 1.4 (s, 3H), 1.4 (s, 3H), 1.3 (d, J = 7.1 Hz, 3H). 
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(S,S)-Methyl (3-hydroxy-3-methyl-2-((4-nitrophenyl)sulfonamido)butanoyl)valinate (47). Parent 
dipeptide Ns-Val-Val-OMe was oxidized to the title compound using General Procedure C (slow addition 
protocol) with standard oxidant equivalents.  The reaction was concentrated and purified via flash 
column chromatography on silica gel to afford the title compound as a white solid in 37% yield (51% 
recovered starting material).  (12% by mass of a combination of other oxidized products were also 
isolated, but were inseparable by flash chromatography). 1H NMR (500 MHz, Chloroform-d) δ 8.3 (d, J = 
8.7 Hz, 2H), 8.1 (d, J = 8.7 Hz, 2H), 6.9 (d, J = 8.8 Hz, 1H), 6.4 (d, J = 9.3 Hz, 1H), 4.2 (dd, J = 8.9, 4.7 Hz, 
1H), 3.8 (d, J = 9.4 Hz, 1H), 3.7 (s, 3H), 2.0 (dt, J = 7.1, 4.9 Hz, 1H), 1.4 (s, 3H), 1.1 (s, 3H), 0.7 (dd, J = 30.2, 
6.8 Hz, 6H).  13C NMR (126 MHz, Chloroform-d) δ 172.7, 169.4, 150.1, 145.5, 128.8, 124.3, 72.8, 63.7, 
57.7, 52.7, 30.3, 27.7, 24.7, 18.9, 17.4 . 
 
(S,S)-Methyl 2-(5-hydroxy-1-((4-nitrophenyl)sulfonyl)pyrrolidine-2-carboxamido)pentanoate (51).  
Parent dipeptide Ns-Pro-Nle-OMe was oxidized to the title compound using General Procedure A 
(iterative addition protocol).  The reaction was concentrated and purified via flash column 
chromatography on silica gel to afford the title compound as a white solid in 37% yield (32% recovered 
starting material). The product was isolated as an inseparable mixture of diastereomers in a 5.4:1 ratio 
(major diast. peaks listed).  1H NMR (500 MHz, Chloroform-d) δ 8.3 (d, J = 8.6 Hz, 2H), 8.1 (d, J = 8.4 Hz, 
2H), 7.0 (d, J = 7.9 Hz, 1H), 5.8 – 5.7 (m, 1H), 4.6 – 4.4 (m, 1H), 4.3 (dd, J = 8.1, 4.2 Hz, 1H), 4.1 (d, J = 6.6 
Hz, 1H), 3.7 (s, 3H), 2.3 – 2.1 (m, 2H), 1.9 (ddd, J = 11.7, 7.6, 4.1 Hz, 1H), 1.8 – 1.7 (m, 1H), 1.7 – 1.6 (m, 
1H), 1.3 (ddd, J = 8.7, 6.1, 2.4 Hz, 2H), 0.9 (t, J = 7.3 Hz, 3H). 
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